137 related articles for article (PubMed ID: 34237344)
1. Quality of life and toxicity guided treatment plan optimisation for head and neck cancer.
van der Laan HP; van der Schaaf A; Van den Bosch L; Korevaar EW; Steenbakkers RJHM; Both S; Langendijk JA
Radiother Oncol; 2021 Sep; 162():85-90. PubMed ID: 34237344
[TBL] [Abstract][Full Text] [Related]
2. Direct use of multivariable normal tissue complication probability models in treatment plan optimisation for individualised head and neck cancer radiotherapy produces clinically acceptable treatment plans.
Kierkels RG; Korevaar EW; Steenbakkers RJ; Janssen T; van't Veld AA; Langendijk JA; Schilstra C; van der Schaaf A
Radiother Oncol; 2014 Sep; 112(3):430-6. PubMed ID: 25220369
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
[TBL] [Abstract][Full Text] [Related]
4. Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: is there a place for critical swallowing structures dose sparing?
Cilla S; Deodato F; Macchia G; Digesù C; Ianiro A; Piermattei A; Valentini V; Morganti AG
Br J Radiol; 2016; 89(1059):20150764. PubMed ID: 26728543
[TBL] [Abstract][Full Text] [Related]
5. Impact of radiation-induced toxicities on quality of life of patients treated for head and neck cancer.
van der Laan HP; Van den Bosch L; Schuit E; Steenbakkers RJHM; van der Schaaf A; Langendijk JA
Radiother Oncol; 2021 Jul; 160():47-53. PubMed ID: 33892023
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Multi-Criteria Optimization-based Trade-Off exploration in combination with RapidPlan for head & neck radiotherapy planning.
Miguel-Chumacero E; Currie G; Johnston A; Currie S
Radiat Oncol; 2018 Nov; 13(1):229. PubMed ID: 30470254
[TBL] [Abstract][Full Text] [Related]
7. Multivariable normal tissue complication probability model-based treatment plan optimization for grade 2-4 dysphagia and tube feeding dependence in head and neck radiotherapy.
Kierkels RGJ; Wopken K; Visser R; Korevaar EW; van der Schaaf A; Bijl HP; Langendijk JA
Radiother Oncol; 2016 Dec; 121(3):374-380. PubMed ID: 27614681
[TBL] [Abstract][Full Text] [Related]
8. First experience with model-based selection of head and neck cancer patients for proton therapy.
Tambas M; Steenbakkers RJHM; van der Laan HP; Wolters AM; Kierkels RGJ; Scandurra D; Korevaar EW; Oldehinkel E; van Zon-Meijer TWH; Both S; van den Hoek JGM; Langendijk JA
Radiother Oncol; 2020 Oct; 151():206-213. PubMed ID: 32768508
[TBL] [Abstract][Full Text] [Related]
9. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY
World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322
[TBL] [Abstract][Full Text] [Related]
10. Composite minimax robust optimization of VMAT improves target coverage and reduces non-target dose in head and neck cancer patients.
Wagenaar D; Kierkels RGJ; Free J; Langendijk JA; Both S; Korevaar EW
Radiother Oncol; 2019 Jul; 136():71-77. PubMed ID: 31015132
[TBL] [Abstract][Full Text] [Related]
11. Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients.
Hamming-Vrieze O; Depauw N; Craft DL; Chan AW; Rasch CRN; Verheij M; Sonke JJ; Kooy HM
Phys Med Biol; 2019 Apr; 64(9):095001. PubMed ID: 30921775
[TBL] [Abstract][Full Text] [Related]
12. A method for a priori estimation of best feasible DVH for organs-at-risk: Validation for head and neck VMAT planning.
Ahmed S; Nelms B; Gintz D; Caudell J; Zhang G; Moros EG; Feygelman V
Med Phys; 2017 Oct; 44(10):5486-5497. PubMed ID: 28777469
[TBL] [Abstract][Full Text] [Related]
13. Patient anatomy-specific trade-offs between sub-clinical disease coverage and normal tissue dose reduction in head-and-neck cancer.
Kaplan LP; Holm AIS; Eriksen JG; Heijmen BJM; Korreman SS; Rossi L
Radiother Oncol; 2023 May; 182():109526. PubMed ID: 36764458
[TBL] [Abstract][Full Text] [Related]
14. Assessment of PlanIQ Feasibility DVH for head and neck treatment planning.
Fried DV; Chera BS; Das SK
J Appl Clin Med Phys; 2017 Sep; 18(5):245-250. PubMed ID: 28857470
[TBL] [Abstract][Full Text] [Related]
15. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
[TBL] [Abstract][Full Text] [Related]
16. [Not Available].
Behrends C; Haussmann J; Kramer PH; Langendijk JA; Gottschlag H; Geismar D; Budach W; Timmermann B
Z Med Phys; 2021 Feb; 31(1):5-15. PubMed ID: 33358063
[TBL] [Abstract][Full Text] [Related]
17. Physical and Radiobiological Evaluation of Accelerated Intensity Modulated Radiotherapy for Locally Advanced Head and Neck Cancer and Comparison with Short-Term Clinical Outcomes.
Buchapudi RR; Manickam R; M R AK; C R TP; Chandraraj V; Pyakuryal A; Narayanasamy G
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2463-2470. PubMed ID: 31450921
[TBL] [Abstract][Full Text] [Related]
18. SPECT/CT-guided elective nodal irradiation for head and neck cancer: Estimation of clinical benefits using NTCP models.
de Veij Mestdagh PD; Janssen T; Lamers E; Carbaat C; Hamming-Vrieze O; Vogel WV; Sonke JJ; Al-Mamgani A
Radiother Oncol; 2019 Jan; 130():18-24. PubMed ID: 30087057
[TBL] [Abstract][Full Text] [Related]
19. Multicriteria optimization enables less experienced planners to efficiently produce high quality treatment plans in head and neck cancer radiotherapy.
Kierkels RG; Visser R; Bijl HP; Langendijk JA; van 't Veld AA; Steenbakkers RJ; Korevaar EW
Radiat Oncol; 2015 Apr; 10():87. PubMed ID: 25885444
[TBL] [Abstract][Full Text] [Related]
20. The role of the soft palate dose regarding normal tissue toxicities in older adults with head and neck cancer undergoing definitive radiotherapy.
Bitz HC; Sachpazidis I; Zou J; Schnell D; Baltas D; Grosu AL; Nicolay NH; Rühle A
Radiat Oncol; 2024 Apr; 19(1):53. PubMed ID: 38689338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
